Junichi Matsumoto
Ebetsu, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Erythropoietin Resistance and Outcomes According to SGLT2 Inhibitor Use in Anemic Patients With Heart Failure.
Journal: Journal of cardiac failure
Published: July 01, 2026
Erythropoietin Resistance and Outcomes According to SGLT2 Inhibitor Use in Anemic Patients With Heart Failure.
Journal: Journal of cardiac failure
Published: July 01, 2026
Temporal Changes in Guideline-Directed Medical Therapy Score and Clinical Outcomes in Patients with Heart Failure.
Journal: European heart journal. Quality of care & clinical outcomes
Published: May 06, 2026
Prognostic Value of Mid-Range QRS Duration in Patients With Heart Failure With Reduced Ejection Fraction.
Journal: Circulation journal : official journal of the Japanese Circulation Society
Published: April 26, 2026
Prognostic Value of New Proposed Criteria for Atrial Cardiomyopathy in Patients With Heart Failure.
Journal: JACC. Advances
Published: April 01, 2026
Clinical Phenotyping and Treatment Response in Patients With Chronic Heart Failure.
Journal: JACC. Advances
Published: January 14, 2025
Prognostic Value of Reticulocyte Production Ability in Patients With Chronic Heart Failure.
Journal: The Canadian journal of cardiology
Published: October 24, 2024
Brain-Derived Neurotrophic Factor Improves Impaired Fatty Acid Oxidation Via the Activation of Adenosine Monophosphate-Activated Protein Kinase-ɑ - Proliferator-Activated Receptor-r Coactivator-1ɑ Signaling in Skeletal Muscle of Mice With Heart Failure.
Journal: Circulation. Heart failure
Published: December 28, 2020
Cardiac-specific loss of mitoNEET expression is linked with age-related heart failure.
Journal: Communications biology
Published: February 02, 2020
Inhibition of xanthine oxidase in the acute phase of myocardial infarction prevents skeletal muscle abnormalities and exercise intolerance.
Journal: Cardiovascular research
Published: January 15, 2020
Empagliflozin restores lowered exercise endurance capacity via the activation of skeletal muscle fatty acid oxidation in a murine model of heart failure.
Journal: European journal of pharmacology
Published: October 13, 2019
Angiotensin-converting-enzyme inhibitor prevents skeletal muscle fibrosis in myocardial infarction mice.
Journal: Skeletal muscle
Published: September 09, 2019
Last Updated: 09/26/2026